In-Office Dispensing Primary CareMany primary care practices still don’t have in-house dispensing, but that is changing as 2014 rolls into 2015. This year, many are talking about how medical practices are running operations in ways they have not or had not considered doing previously. The big drives?

How to make money and how to improve patient care.

Primary care clinics have seen a dramatic rise in patient numbers as a greater number of patients have access to healthcare in 2014. Practices are looking for ways to not only serve their growing population but to keep them coming through the doors. One of the best ways to achieve that is to leverage a solution that both adds revenue and focuses on improving patient care.

According to a study conducted by Harvard Medical School, more than 20 percent of first-time patient prescriptions are never filled. One of the major reasons for this is convenience. The same study has shown that when patients receive the medication at the time of their office visit, they not only receive instructions and encouragement as to using the prescription, but the physicians know that the patient has picked up the medication. The benefits that speak to improving patient care?

Greater adherence to medication regimens, improved compliance, and as a result better outcomes.

Don’t these sound like benefits your primary care practice would like to enjoy?

While adding in-house dispensing is a great way to add a supplemental revenue stream, perhaps the best benefit of all is improving care across the board for your patients. And while you’re helping to improve care, you’re branding your practice as one that values convenience, loyalty and more.

Start a Conversation with Northwind Pharmaceuticals Today!

Don’t stay behind the trend when it comes to improving patient outcomes and adding revenue streams to your bottom line. Talk to us today about how to integrate in-office dispensing.

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading